Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunoregulatory functions of VISTA

1 Mar 2017

Abstract excerpt

Utilization of negative checkpoint regulators (NCRs) for cancer immunotherapy has garnered significant interest with the completion of clinical trials demonstrating efficacy. While the results of monotherapy treatments are compelling, there is increasing emphasis on combination treatments in an effort to increase response rates to treatment. One of the most recently discovered NCRs is VISTA (V-domain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28258694
DOI: 10.1111/imr.12525

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunoregulatory functions of VISTAPMID 28258694Read ↗

VISTA-mediated immune evasion in cancerSemantic proximity Read ↗

A New VISTA on combination therapy for negative checkpoint regulator blockadeSemantic proximity Read ↗

VISTA expression and patient selection for immune-based anticancer therapySemantic proximity Read ↗

VISTA: A Promising Target for Cancer Immunotherapy?Semantic proximity Read ↗

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapySemantic proximity Read ↗

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlightsSemantic proximity Read ↗

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesSemantic proximity Read ↗

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapySemantic proximity Read ↗

Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell ActivationSemantic proximity Read ↗

Tumor immune checkpoints and their associated inhibitorsSemantic proximity Read ↗

Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 – Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T LymphocytesSemantic proximity Read ↗

The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.